Frank Litvack - Mar 3, 2025 Form 4 Insider Report for CAPRICOR THERAPEUTICS, INC. (CAPR)

Role
Director
Signature
/s/ Linda Marban, Attorney-in-Fact
Stock symbol
CAPR
Transactions as of
Mar 3, 2025
Transactions value $
-$13
Form type
4
Date filed
3/4/2025, 07:00 PM
Previous filing
Jan 6, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CAPR Common Stock Options Exercise $34.8K +25K +23.28% $1.39 132K Mar 3, 2025 Direct
transaction CAPR Common Stock Tax liability -$34.8K -2.54K -1.92% $13.67 130K Mar 3, 2025 Direct F1
holding CAPR Common Stock 46.3K Mar 3, 2025 Held in Family Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CAPR Stock Option (Right to Buy) Options Exercise $0 -25K -100% $0.00 0 Mar 3, 2025 Common Stock 25K $1.39 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a "net exercise" of outstanding stock options. These shares were withheld by the Issuer for payment of the exercise price, based on the closing market price of the Issuer's common stock on March 3, 2025 of $13.67. The options would otherwise expire on March 3, 2025, pursuant to their terms.
F2 Held by Litvack Curtis Family Trust for which the Reporting Person serves as trustee.
F3 This option was granted on March 3, 2015 and was previously reported as covering 250,000 shares at an exercise price of $5.78 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020.
F4 Shares vested 1/48th on the first day of each month commencing April 1, 2015.